Inventor
TREON STEVEN P
US15 patents
⚠️ This page may combine multiple inventors who share the name “TREON STEVEN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
13 patentsUS10112957B2Oct 30, 2018
Thiazolyl-containing compounds for treating proliferative diseases
DANA FARBER CANCER INST INC5 citations83
US9908872B2Mar 6, 2018
Methods to treat lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC6 citations83
US9856223B2Jan 2, 2018
Methods to treat lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC6 citations83
US10525060B2Jan 7, 2020
HCK as a therapeutic target in MYD88 mutated diseases
DANA FARBER CANCER INST INC5 citations72
US10464949B2Nov 5, 2019
Thiazolyl-containing compounds for treating proliferative diseases
DANA FARBER CANCER INST INC2 citations72
US10526660B2Jan 7, 2020
Methods for evaluating and treating Waldenstrom's macroglobulinemia
DANA FARBER CANCER INST INC2 citations68
US12564591B2Mar 3, 2026
HCK as a therapeutic target in MYD88 mutated diseases
DANA FARBER CANCER INST INC0 citations62
USRE50030EJul 2, 2024
Methods to treat lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC0 citations62
US10633348B2Apr 28, 2020
Methods to treat lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC1 citations62
US10597387B2Mar 24, 2020
Methods to treat lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC1 citations62
US11739385B2Aug 29, 2023
Discovery of a somatic mutation in MYD88 gene in lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC1 citations61
US10612095B2Apr 7, 2020
Methods to distinguish Waldenström's Macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
DANA FARBER CANCER INST INC1 citations56
US10844077B2Nov 24, 2020
Thiazolyl-containing compounds for treating proliferative diseases
DANA FARBER CANCER INST INC0 citations51